Ana Sánchez Cuesta

Ana Sánchez Cuesta

Auto-generated profile, based on publicly available information

Ana Sánchez Cuesta

Departamento de Fisiología, Anatomía y Biología Celular, CABD Universidad Pablo de Olavide Sevilla Spain

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2021 in BioFactors
Verified
Journal Article
Closed access
PDF file
Plácido NavasPlácido Navas
Plácido Navas
MCMaria Victoria Cascajo
Maria Victoria Cascajo
MAMaría Alcázar‐Fabra
María Alcázar‐Fabra
JHJuan D. Hernández‐Camacho
Juan D. Hernández‐Camacho
ASAna Sánchez‐Cuesta
Ana Sánchez‐Cuesta
Carlos Santos-OcañaCarlos Santos-Ocaña
Carlos Santos-Ocaña

8 July 2024 in Journal of Inherited Metabolic Disease
Verified
Journal Article
Open access
MFMaría Alcázar Fabra
María Alcázar Fabra
APAbraham J. Paredes-Fuentes
Abraham J. Paredes-Fuentes
MCManuel Torralba Carnerero
Manuel Torralba Carnerero
DFDaniel José Moreno Fernández-Ayala
Daniel José Moreno Fernández-Ayala
ALAntonio Arroyo Luque
Antonio Arroyo Luque
Carlos Santos-OcañaCarlos Santos-Ocaña
Carlos Santos-Ocaña
The protein encoded by COQ7 is required for CoQ10 synthesis in humans, hydroxylating 3‐demethoxyubiquinol (DMQ10) in the second to last steps of the pathway. COQ7 mutations lead to a primary CoQ10 deficiency syndrome associated with a pleiotropic neurological disorder. This study shows the clinical, physiological, and molecular characterization of four new cases of CoQ10 primary deficiency caused by five mutations in COQ7, three of which have not yet been described, inducing mitochondrial dysfunction in all patients. However, the specific combination of the identified variants in each patient generated precise pathophysiological and molecular alterations in fibroblasts, which would explain the differential in vitro response to supplementation therapy. Our results suggest that COQ7 dysfunction could be caused by specific structural changes that affect the interaction with COQ9 required for the DMQ10 presentation to COQ7, the substrate access to the active site, and the maintenance of the active site structure. Remarkably, patients' fibroblasts share transcriptional remodeling, supporting a modification of energy metabolism towards glycolysis, which could be an adaptive mechanism against CoQ10 deficiency. However, transcriptional analysis of mitochondria‐associated pathways showed distinct and dramatic differences between patient fibroblasts, which correlated with the extent of pathophysiological and neurological alterations observed in the probands. Overall, this study suggests that the combination of precise genetic diagnostics and the availability of new structural models of human proteins could help explain the origin of phenotypic pleiotropy observed in some genetic diseases and the different responses to available therapies.

10 February 2022 in Journal of Visualized Experiments
Verified
Journal Article
Closed access
PDF file
JHJuan Diego Hernández-Camacho
Juan Diego Hernández-Camacho
CVCristina Vicente-García
Cristina Vicente-García
ASAna Sánchez-Cuesta
Ana Sánchez-Cuesta
DFDaniel José Moreno Fernández-Ayala
Daniel José Moreno Fernández-Ayala
JCJaime J. Carvajal
Jaime J. Carvajal
Plácido NavasPlácido Navas
Plácido Navas
Most of the cell's energy is obtained through the degradation of glucose, fatty acids, and amino acids by different pathways that converge on the mitochondrial oxidative phosphorylation (OXPHOS) system, which is regulated in response to cellular demands. The lipid molecule Coenzyme Q (CoQ) is essential in this process by transferring electrons to complex III in the electron transport chain (ETC) through constant oxidation/reduction cycles. Mitochondria status and, ultimately, cellular health can be assessed by measuring ETC oxygen consumption using respirometric assays. These studies are typically performed in established or primary cell lines that have been cultured for several days. In both cases, the respiration parameters obtained may have deviated from normal physiological conditions in any given organ or tissue. Additionally, the intrinsic characteristics of cultured single fibers isolated from skeletal muscle impede this type of analysis. This paper presents an updated and detailed protocol for the analysis of respiration in freshly isolated mitochondria from mouse skeletal muscle. We also provide solutions to potential problems that could arise at any step of the process. The method presented here could be applied to compare oxygen consumption rates in diverse transgenic mouse models and study the mitochondrial response to drug treatments or other factors such as aging or sex. This is a feasible method to respond to crucial questions about mitochondrial bioenergetics metabolism and regulation.